First-Line Treatment for Moderate Epididymitis
The first-line treatment for moderate epididymitis depends critically on patient age and sexual history: for sexually active men under 35 years, use ceftriaxone 1g IM single dose plus doxycycline 100mg twice daily for 7-10 days; for men over 35 years or those with enteric pathogen risk, use levofloxacin or ofloxacin monotherapy for 10 days 1, 2.
Treatment Algorithm by Patient Profile
Sexually Active Men <35 Years (STI-Associated)
The predominant pathogens are Chlamydia trachomatis and Neisseria gonorrhoeae 1, 3. The 2024 European guidelines recommend:
- Ceftriaxone 1g IM single dose (increased from previous 500mg dose)
- PLUS Doxycycline 100mg twice daily for 7-10 days 1, 2
Critical update: Dual therapy with azithromycin is no longer recommended unless cefixime is substituted for ceftriaxone 2. This represents an important shift from older practices.
Men with Mixed Risk (STI + Enteric Pathogens)
This includes men who practice insertive anal intercourse or have other risk factors for enteric organisms 3:
- Ceftriaxone 1g IM single dose
- PLUS either Levofloxacin 500mg daily OR Ofloxacin 200mg twice daily for 10 days 1, 2
This dual coverage addresses both sexually transmitted and enteric bacteria.
Men >35 Years or Enteric Pathogen Suspicion
In this population, enteric bacteria (Enterobacterales) predominate, typically from urinary reflux secondary to bladder outlet obstruction 1, 3:
Monotherapy with fluoroquinolones is sufficient as these agents provide adequate coverage for enteric organisms 4.
Important Clinical Considerations
Common Pitfalls to Avoid
Do not use ciprofloxacin as first-line therapy in young, sexually active men—it lacks adequate anti-chlamydial activity despite being historically popular 5. This represents a critical prescribing error that persists in clinical practice.
Do not assume absence of STI risk based on sexual history alone—up to two-thirds of men with epididymitis do not report dysuria or urethritis symptoms, and sexually transmitted pathogens are regularly found even in men with unremarkable sexual histories 6.
Special Populations
Patients with indwelling catheters require empiric dual therapy with both a fluoroquinolone AND third-generation cephalosporin until susceptibility testing is available, due to high rates of multidrug resistance 6.
Duration and Follow-Up
Treatment duration is typically 7-10 days for most regimens 1, 2, 3. Inadequate treatment can lead to serious complications including infertility (affecting 40% of patients), chronic scrotal pain, abscess formation, and testicular infarction 3, 6.
Refer all young men with suspected STI-related epididymitis to sexual health services for contact tracing and partner treatment 5.